Concurrent modulation of anxiety and memory

Behavioural Brain Research

Volumn 109, Issue 2, 2000, Pages 229-241

  Wall, Philip M ^a   Messier, Claude ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Anxiety; Current modulation; Elevated plus maze; Memory; Opioid receptors; Ventromedial prefrontal cortex; Y mase

Indexed keywords

KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; BEHAVIOR; BRAIN STEM; CONTROLLED STUDY; DRUG EFFECT; FOREBRAIN; LIMBIC CORTEX; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; REVIEW; WORKING MEMORY;

EID: 0034028488     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(99)00177-1     Document Type: Article

References (131)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52:1989;1655-1658.
2. Agmo A., Belzung C. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide. Neuropharmacology. 37:1998;223-232.
3. Almeida S.S., Garcia R.A., de Oliveira L.M. Effects of early protein malnutrition and repeated testing upon locomotor and exploratory behaviors in the elevated plus-maze. Physiol. Behav. 54:1993;749-752.
4. Andrews N., File S.E. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. Eur. J. Pharmacol. 235:1993;109-112.
5. Bachevalier J., Mishkin M. Visual recognition impairment follows ventromedial but not dorsolateral prefrontal lesions in monkeys. Behav. Brain Res. 20:1986;249-261.
6. Bals-Kubik R., Ableitner A., Herz A., Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264:1993;489-495.
7. Berntson G.G., Hart S., Ruland S., Sarter M. A central cholinergic link in the cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG 7142. Behav. Brain Res. 74:1996;91-103.
8. Berntson G.G., Sarter M., Cacioppo J.T. Anxiety and cardiovascular reactivity: the basal forebrain cholinergic link. Behav. Brain Res. 94:1998;225-248.
9. Bertolucci-D'Angio M., Serrano A., Scatton B. Mesocorticolimbic dopaminergic systems and emotional states. J. Neurosci. Methods. 34:1990;135-142.
10. Bremner J.D., Staib L.H., Kaloupek D., Southwick S.M., Soufer R., Charney D.S. Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol. Psych. 45:1999;806-816.
11. Broersen L.M., Heinsbroek R.P., de Bruin J.P., Uylings H.B., Olivier B. The role of the medial prefrontal cortex of rats in short-term memory functioning: further support for involvement of cholinergic, rather than dopaminergic mechanisms. Brain Res. 674:1995;221-229.
12. Carlson J.N., Fitzgerald L.W., Keller R.W., Glick S.D. Side and region dependent changes in dopamine activation with various durations of restraint stress. Brain Res. 550:1991;313-318.
13. Chiba A.A., Kesner R.P., Reynolds A.M. Memory for spatial location as a function of temporal lag in rats: role of hippocampus and medial prefrontal cortex. Behav. Neural. Biol. 61:1994;123-131.
14. Cole J.C., Rodgers R.J. Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol. Psychopharmacology (Berl). 114:1994;288-296.
15. Cole J.C., Rodgers R.J. Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. Pharmacol. Biochem. Behav. 52:1995;473-478.
16. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176.
17. Dawson G.R., Crawford S.P., Stanhope K.J., Iversen S.D., Tricklebank M.D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology (Berl). 113:1994;570-572.
18. Derrien M., Durieux C., Dauge V., Roques B.P. Involvement of D2 dopaminergic receptors in the emotional and motivational responses induced by injection of CCK-8 in the posterior part of the rat nucleus accumbens. Brain Res. 617:1993;181-188.
19. Deutch A.Y., Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog. Brain Res. 85:1990;367-402.
20. Dietrich A., Allen J.D. Functional dissociation of the prefrontal cortex and the hippocampus in timing behavior. Behav. Neurosci. 112:1998;1043-1047.
21. Donzanti B.A., Althaus J.S., Payson M.M., Von Voigtlander P.F. Kappa agonist-induced reduction in dopamine release: site of action and tolerance. Res. Commun. Chem. Pathol. Pharmacol. 78:1992;193-210.
22. Drevets W.C., Videen T.O., Snyder A.Z., Macleod A.K., Raichle M.E. Regional cerebral blood flow changes during anticipatory anxiety. Soc. Neurosci. Abstr. 20:1994;368.
23. Duncan G.E., Knapp D.J., Breese G.R. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res. 713:1996;79-91.
24. Dunn A.J., File S.E. Cold restraint alters dopamine metabolism in frontal cortex, nucleus accumbens and neostriatum. Physiol. Behav. 31:1983;511-513.
25. Dunnett S.B. Role of prefrontal cortex and striatal output systems in short-term memory deficits associated with ageing, basal forebrain lesions, and cholinergic-rich grafts. Can. J. Psychol. 44:1990;210-232.
26. Elliott R., Dolan R.J. Neural response during preference and memory judgments for subliminally presented stimuli: a functional neuroimaging study. J. Neurosci. 18:1998;4697-4704.
27. Endoh T., Koike H., Matsumuura H., Nagase H. nor-Binaltorphamine (nor-BNI); a potent and selective kappa opioid receptor antagonist with ultra-long-lasting activity in vivo. 1990;82-83 Elsevier Science Publishers, Amsterdam, The Netherlands.
28. Espejo E.F. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behav. Brain Res. 87:1997;233-238.
29. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav. 54:1996;31-40.
30. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 58:1993;199-202.
31. File S.E., Zangrossi H., Viana M., Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear. Psychopharmacology. 111:1993;491-494.
32. Franklin K.B.J., Paxinos G. The mouse brain: In: Stereotaxic Coordinates. 1997;Academic Press, New York.
33. Fritts M.E., Asbury E.T., Horton J.E., Isaac W.L. Medial prefrontal lesion deficits involving or sparing the prelimbic area in the rat. Physiol. Behav. 64:1998;373-380.
34. Gabriel M. Functions of anterior and posterior cingulate cortex during avoidance learning in rabbits. Prog. Brain Res. 85:1990;467-482.
35. Gold P.W., Chrousos G.P. The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc. Assoc. Am. Physicians. 111:1999;22-34.
36. Goldman-Rakic P.S. Cellular basis of working memory. Neuron. 14:1995;477-485.
37. Goldman-Rakic P.S. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 351:1996;1445-1453.
38. Goldman-Rakic P.S. Regional and cellular fractionation of working memory. Proc. Natl. Acad. Sci. USA. 93:1996;13473-13480.
39. Goldman-Rakic P.S. The cortical dopamine system: role in memory and cognition. Adv. Pharmacol. 42:1998;707-711.
40. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia (see comments). Schizophr. Bull. 23:1997;437-458.
41. Goldstein L.E., Rasmusson A.M., Bunney B.S., Roth R.H. The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat. J. Neurosci. 14:1994;4937-4950.
42. Goldstein L.E., Rasmusson A.M., Bunney B.S., Roth R.H. Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J. Neurosci. 16:1996;4787-4798.
43. Gonzalez L.E., File S.E. A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J. Neurosci. 17:1997;1505-1511.
44. Granon S., Poucet B., Thinus-Blanc C., Changeux J.P., Vidal C. Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology (Berl). 119:1995;139-144.
45. Granon S., Vidal C., Thinus-Blanc C., Changeux J.P., Poucet B. Working memory, response selection, and effortful processing in rats with medial prefrontal lesions. Behav. Neurosci. 108:1994;883-891.
46. Hasselmo M.E. Neuromodulation and cortical function: modeling the physiological basis of behavior. Behav. Brain Res. 67:1995;1-27.
47. Heinsbroek R.P., van Haaren F., Feenstra M.G., Boon P., van de Poll N.E. Controllable and uncontrollable footshock and monoaminergic activity in the frontal cortex of male and female rats. Brain Res. 551:1991;247-255.
48. Herman J.P., Guillonneau D., Dantzer R., Scatton B., Semerdjian-Rouquier L., Le Moal M. Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshocks on dopamine turnover in cortical and limbic areas of the rat. Life Sci. 30:1982;2207-2214.
49. Herremans A.H., Hijzen T.H., Welborn P.F., Olivier B., Slangen J.L. Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat. Brain Res. 711:1996;102-111.
50. Hiramatsu M., Hyodo T., Kameyama T. U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice. Eur. J. Pharmacol. 315:1996;119-125.
51. Hiramatsu M., Murasawa H., Mori H., Kameyama T. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist. Br. J. Pharmacol. 123:1998;920-926.
52. Hiramatsu M., Murasawa H., Nabeshima T., Kameyama T. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine- induced learning and memory impairment in rats. J. Pharmacol. Exp. Ther. 284:1998;858-867.
53. Hiramatsu M., Sasaki M., Nabeshima T., Kameyama T. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice. Pharmacol. Biochem. Behav. 56:1997;73-79.
54. Holmes A., Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state. Pharmacol. Biochem. Behav. 60:1998;473-488.
55. Horan P., Taylor J., Yamamura H.I., Porreca F. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test. J. Pharmacol. Exp. Ther. 260:1992;1237-1243.
56. Inglis W.L., Dunbar J.S., Winn P. Outflow from the nucleus accumbens to the pedunculopontine tegmental nucleus: a dissociation between locomotor activity and the acquisition of responding for conditioned reinforcement stimulated by D-amphetamine. Neuroscience. 62:1994;51-64.
57. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur. J. Pharmacol. 194:1991;71-76.
58. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice. Eur. J. Pharmacol. 236:1993;341-345.
59. Itoh J., Ukai M., Kameyama T. U-50,488H, a kappa-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice. Brain Res. 619:1993;223-228.
60. Itoh J., Ukai M., Kameyama T. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice. J. Pharmacol. Exp. Ther. 269:1994;15-21.
61. Izumi T. Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety. Hokkaido Igaku Zasshi. 73:1998;463-473.
62. Jinks A.L., McGregor I.S. Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res. 772:1997;181-190.
63. Jones B.E., Cuello A.C. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic - catecholamine, serotonin, and acetylcholine - neurons. Neuroscience. 31:1989;37-61.
64. Jones D.N., Holtzman S.G. Long term kappa-opioid receptor blockade following nor-binaltorphimine. Eur. J. Pharmacol. 215:1992;345-348.
65. Jones E.G., Hendry S.H. Peptide-containing neurons of the primate cerebral cortex. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 64:1986;163-178.
66. Jung M.W., Qin Y., McNaughton B.L., Barnes C.A. Firing characteristics of deep layer neurons in prefrontal cortex in rats performing spatial working memory tasks. Cereb. Cortex. 8:1998;437-450.
67. Kesner R.P. Memory for frequency in rats: role of the hippocampus and medial prefrontal cortex. Behav. Neural. Biol. 53:1990;402-410.
68. Lang A.J., Craske M.G. Information processing in anxiety and depression. Behav. Res. Ther. 35:1997;451-455.
69. Leri F., Franklin K.B. Learning impairments caused by lesions to the pedunculopontine tegmental nucleus: an artifact of anxiety. Brain Res. 807:1998;187-192.
70. Liang K.C., Hu S.J., Chang S.C. Formation and retrieval of inhibitory avoidance memory: differential roles of glutamate receptors in the amygdala and medial prefrontal cortex. Chin. J. Physiol. 39:1996;155-166.
71. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
72. MacLeod C., McLaughlin K. Implicit and explicit memory bias in anxiety: a conceptual replication. Behav. Res. Ther. 33:1995;1-14.
73. Maguire E.A., Mummery C.J. Differential modulation of a common memory retrieval network revealed by positron emission tomography (In Process Citation). Hippocampus. 9:1999;54-61.
74. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29.
75. Manzanares J., Lookingland K.J., LaVigne S.D., Moore K.E. Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist NOR-binaltorphimine. Life Sci. 48:1991;1143-1149.
76. Manzanares J., Lookingland K.J., Moore K.E. Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain. J. Pharmacol. Exp. Ther. 256:1991;500-505.
77. Mathews A., Mogg K., Kentish J., Eysenck M. Effect of psychological treatment on cognitive bias in generalized anxiety disorder. Behav. Res. Ther. 33:1995;293-303.
78. Mathews A., Mogg K., May J., Eysenck M. Implicit and explicit memory bias in anxiety. J. Abnorm. Psychol. 98:1989;236-240.
79. McNally R.J. Memory and anxiety disorders. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 352:1997;1755-1759.
80. Messier C., Emond S., Ethier K. New techniques in stereotaxic surgery and anesthesia in the mouse. Pharmacol. Biochem. Behav. 63:1999;313-318.
81. Mogensen J., Holm S. The prefrontal cortex and variants of sequential behaviour indications of functional differentiation between subdivisions of the rat's prefrontal cortex. Behav. Brain Res. 63:1994;89-100.
82. Morgan M.A., LeDoux J.E. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav. Neurosci. 109:1995;681-688.
83. Morgan M.A., Romanski L.M., LeDoux J.E. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci. Lett. 163:1993;109-113.
84. Muir J.L., Dunnett S.B., Robbins T.W., Everitt B.J. Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp. Brain Res. 89:1992;611-622.
85. Murphy B.L., Arnsten A.F., Goldman-Rakic P.S., Roth R.H. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. USA. 93:1996;1325-1329.
86. Murphy B.L., Arnsten A.F., Jentsch J.D., Roth R.H. Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J. Neurosci. 16:1996;7768-7775.
87. Olson G.A., Olson R.D., Kastin A.J. Endogenous opiates: 1992. Peptides. 1993:14;1339-1378.
88. Olson G.A., Olson R.D., Kastin A.J. Endogenous opiates:1992. Peptides. 1994:15;1513-1556.
89. Penna A.M., Lee S.Y., Scheidegger da Silva L., Oliveira R.W., de Freitas Gomes C., Nakamura Palacios E.M. Behavioral and cognitive effects produced by electrical stimulation in the medial prefrontal cortex: an experimental model for high cortical activation. Neuropsychobiology. 38:1998;241-250.
90. Peretti C.S. Anxiety and cognition disorders. Encephale. 24:1998;256-259.
91. Petty F., Jordan S., Kramer G.L., Zukas P.K., Wu J. Benzodiazepine prevention of swim stress-induced sensitization of cortical biogenic amines: an in vivo microdialysis study. Neurochem. Res. 22:1997;1101-1104.
92. Portoghese P.S. Edward E. Smissman-Bristol-Myers Squibb Award Address. The role of concepts in structure-activity relationship studies of opioid ligands. J. Med. Chem. 35:1992;1927-1937.
93. Portoghese P.S., Garzon-Aburbeh A., Nagase H., Lin C.E., Takemori A.E. Role of the spacer in conferring kappa opioid receptor selectivity to bivalent ligands related to norbinaltorphimine. J. Med. Chem. 34:1991;1292-1296.
94. Portoghese P.S., Lipkowski A.W., Takemori A.E. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci. 40:1987;1287-1292.
95. Portoghese P.S., Nagase H., Lipkowski A.W., Larson D.L., Takemori A.E. Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity (published erratum appears in J. Med. Chem. 1988;31(10):2056). J. Med. Chem. 1988:31;836-841.
96. Portoghese P.S., Nagase H., Takemori A.E. Only one pharmacophore is required for the kappa opioid antagonist selectivity of norbinaltorphimine. J. Med. Chem. 31:1988;1344-1347.
97. Poucet B. Searching for spatial unit firing in the prelimbic area of the rat medial prefrontal cortex. Behav. Brain Res. 84:1997;151-159.
98. Ragozzino M.E., Adams S., Kesner R.P. Differential involvement of the dorsal anterior cingulate and prelimbic- infralimbic areas of the rodent prefrontal cortex in spatial working memory. Behav. Neurosci. 112:1998;293-303.
99. Ragozzino M.E., Kesner R.P. The effects of muscarinic cholinergic receptor blockade in the rat anterior cingulate and prelimbic/infralimbic cortices on spatial working memory. Neurobiol. Learn. Mem. 69:1998;241-257.
100. Robbins T.W., Everitt B.J. Arousal systems and attention. Posner M.I. The Cognitive Neurosciences. 1995;703-720 MIT Press, Cambridge, MA.
101. Robbins T.W., Everitt B.J., Marston H.M., Wilkinson J., Jones G.H., Page K.J. Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav. Brain Res. 35:1989;221-240.
102. Rodgers R.J., Cole J.C., Aboualfa K., Stephenson L.H. Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze. Pharmacol. Biochem. Behav. 52:1995;805-813.
103. Rodgers R.J., Johnson N.J. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52:1995;297-303.
104. Rodgers R.J., Johnson N.J., Carr J., Hodgson T.P. Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions. Behav. Brain Res. 86:1997;71-77.
105. Rodgers R.J., Lee C., Shepherd J.K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology. 106:1992;102-110.
106. Rodgers R.J., Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology. 113:1993;237-242.
107. Sanchez-Santed F., de Bruin J.P., Heinsbroek R.P., Verwer R.W. Spatial delayed alternation of rats in a T-maze: effects of neurotoxic lesions of the medial prefrontal cortex and of T-maze rotations. Behav. Brain Res. 84:1997;73-79.
108. Sarter M., Bodewitz G., Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta- carbolines. Psychopharmacology. 94:1988;491-495.
109. Sawchuk C.N., Lohr J.M., Lee T.C., Tolin D.F. Exposure to disgust-evoking imagery and information processing biases in blood-injection-injury phobia. Behav. Res. Ther. 37:1999;249-257.
110. Sesack S.R., Deutch A.Y., Roth R.H., Bunney B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J. Comp. Neurol. 290:1989;213-242.
111. Shippenberg T.S., Bals-Kubik R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 versus D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 265:1993;53-59.
112. Sorg B.A., Kalivas P.W. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience. 53:1993;695-703.
113. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA. 89:1992;2046-2050.
114. Steckler T., Inglis W., Winn P., Sahgal A. The pedunculopontine tegmental nucleus: a role in cognitive processes. Brain Res. Brain Res. Rev. 19:1994;298-318.
115. Swerdlow N.R., Koob G.F. Lesions of the dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Res. 412:1987;233-243.
116. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;463-469.
117. Trullas R., Skolnick P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology. 111:1993;323-331.
118. Tulving E., Markowitsch H.J., Kapur S., Habib R., Houle S. Novelty encoding networks in the human brain: positron emission tomography data. Neuroreport. 5:1994;2525-2528.
119. Unterwald E.M., Knapp C., Zukin R.S. Neuroanatomical localization of kappa 1 and kappa 2 opioid receptors in rat and guinea pig brain. Brain Res. 562:1991;57-65.
120. Unterwald E.M., Rubenfeld J.M., Kreek M.J. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport. 5:1994;1613-1616.
121. Waite J.J., Thal L.J. Lesions of the cholinergic nuclei in the rat basal forebrain: excitotoxins vs. an immunotoxin. Life Sci. 58:1996;1947-1953.
122. Wall PM, Intracerebral Administration of U-69,593 and norBNI in the Medial Prefrontal Cortex and the Ventral Tegmental Area of CD-1 Mice: behavioural evaluation in the elevated Plus Maze, Graduate Thesis, Psychology (Neuroscience), Carleton University, Ottawa, 1997, pp. 150.
123. Wall PM, Messier C. U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice., Brian Res., 2000, in press.
124. Werling L.L., Frattali A., Portoghese P.S., Takemori A.E., Cox B.M. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J. Pharmacol. Exp. Ther. 246:1988;282-286.
125. Wilson F.A. Cortical and subcortical structures involved in recognition memory: neurophysiological and anatomical studies. Int. J. Neurol. 22:1987;204-217.
126. Winn P. Frontal syndrome as a consequence of lesions in the pedunculopontine tegmental nucleus: a short theoretical review (in process citation). Brain Res. Bull. 47:1998;551-563.
127. Yoshioka M., Matsumoto M., Togashi H., Saito H. Effect of conditioned fear stress on dopamine release in the rat prefrontal cortex. Neurosci. Lett. 209:1996;201-203.
128. You Z.B., Herrera-Marschitz M., Nylander I., Goiny M., O'Connor W.T., Ungerstedt U. et al. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis. II. Effects of dopamine D1 and D2 receptor agonists. Neuroscience. 63:1994;427-434.
129. Zaborszky L., Cullinan W.E. Direct catecholaminergic-cholinergic interactions in the basal forebrain. I. Dopamine-beta-hydroxylase- and tyrosine hydroxylase input to cholinergic neurons. J. Comp. Neurol. 374:1996;535-554.
130. Zaborszky L., Cullinan W.E., Braun A. Afferents to basal forebrain cholinergic projection neurons: an update. Adv. Exp. Med. Biol. 295:1991;43-100.
131. Zahrt J., Taylor J.R., Mathew R.G., Arnsten A.F. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J. Neurosci. 17:1997;8528-8535.